Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance.
about
Persistent androgen receptor addiction in castration-resistant prostate cancerResveratrol induces mitochondria-mediated, caspase-independent apoptosis in murine prostate cancer cells.NOD1 deficiency impairs CD44a/Lck as well as PI3K/Akt pathway.Thioridazine Sensitizes Esophageal Carcinoma Cell Lines to Radiotherapy-Induced Apoptosis In Vitro and In Vivo.The PI3K-AKT-mTOR pathway activates recovery from general anesthesiaInduction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation.LncRNA SNHG12 promotes cell growth and inhibits cell apoptosis in colorectal cancer cells.SU6668 modulates prostate cancer progression by downregulating MTDH/AKT signaling pathway.Targeting persistent androgen receptor signaling in castration-resistant prostate cancer.mTOR Inhibitors in Castration-Resistant Prostate Cancer: A Systematic Review.Targeting MicroRNAs in Prostate Cancer Radiotherapy.Up-regulation of miR-497 confers resistance to temozolomide in human glioma cells by targeting mTOR/Bcl-2.Targeting the PI3K/AKT/mTOR signaling pathway as an effectively radiosensitizing strategy for treating human oral squamous cell carcinoma in vitro and in vivo.Long non-coding RNA urothelial carcinoma associated 1 (UCA1) mediates radiation response in prostate cancer.Radiation-resistant cancer stem-like cell properties are regulated by PTEN through the activity of nuclear β-catenin in nasopharyngeal carcinoma.Inhibition of cyclooxygenase-2 sensitizes lung cancer cells to radiation-induced apoptosis.RET Signaling in Prostate Cancer.Targeting DNA repair with PNKP inhibition sensitizes radioresistant prostate cancer cells to high LET radiation.Radiosensitization of the PI3K inhibitor HS-173 through reduction of DNA damage repair in pancreatic cancer.Up-Regulation of PI 3-Kinases and the Activation of PI3K-Akt Signaling Pathway in Cancer Stem-Like Cells Through DNA Hypomethylation Mediated by the Cancer Microenvironment.The prostate cancer immunome: In silico functional analysis of antigenic proteins from microarray profiling with IgG.Transcription Factor HBP1 Enhances Radiosensitivity by Inducing Apoptosis in Prostate Cancer Cell Lines.Targeting Galectin-1 Impairs Castration-Resistant Prostate Cancer Progression and InvasionPAQR3 inhibits proliferation via suppressing PI3K/AKT signaling pathway in non-small cell lung cancerProtectiveness of Artesunate Given Prior Ischemic Cerebral Infarction Is Mediated by Increased AutophagyInhibition of GLUT-1 expression and the PI3K/Akt pathway to enhance the chemosensitivity of laryngeal carcinoma cells in vitroEpithelial cell adhesion molecule (EpCAM) is involved in prostate cancer chemotherapy/radiotherapy response in vivo
P2860
Q26777163-260ABE07-24A8-4023-A48B-BCA0A5E75288Q33591390-2DAC0031-0786-4379-8161-72DD1F2EF524Q33774237-5EA85DF7-BEC6-4303-B59B-048E9438BF80Q37146112-73ADFD16-5DA3-43F2-AD4D-2283A7FB47E3Q37520114-CE527562-D406-4959-888A-89385808779DQ37615676-BDADC129-A8A9-4E49-8CF0-5CDBA4515810Q37677207-C5F94EAC-D892-44A6-9ABA-B21F59E3CFCCQ38710767-457E9F81-A250-4E7E-94D4-036054471797Q38797560-3C59A0A2-7299-4639-8A1C-A09F9D6251DFQ38922287-EA6C8209-FBD8-471F-821A-1D22A8998135Q41239908-ADB6717F-407D-4D48-BF06-2E274675A5C7Q41995095-D50FD734-F790-4815-A2AE-D660C9915E85Q42093380-9645D022-C4DB-4D3A-9141-2C69ED8F23D2Q42182491-C8FB13C8-70B3-4FB8-B1CD-7E72CE3684FFQ47140610-DA05A94D-3998-4F0A-8632-8AE635CAF47EQ47141515-82AD9912-4047-4216-BED8-B7EA788FF5D9Q47890656-7EA74B48-1035-42AC-ABD8-B5D641C2A2EBQ48043803-838770FC-4F14-438E-B666-E1906A990CB4Q49451574-46AAC4C3-C3D8-44E3-B37C-2189824CF2C6Q52721325-D416AF52-46C5-4F38-B1D2-A872735E7B94Q52874472-A3F65071-DF79-49D3-AC0E-538D3FBA0D8FQ53690759-DADA3B5E-79AB-4621-8B47-EF21E5D6C993Q57910094-7D4E6C80-23F1-4E97-94F5-D6F1A0D7BF9DQ58588538-63B65BDA-E1F3-472C-ACFF-9A21C11BA04CQ58769654-DD8F8D23-D4DD-4A8C-A4A9-785E47C99DC8Q59125647-00F8739F-AA15-40C6-8289-F646C3492167Q59136173-16239227-AA10-468A-9166-A3966C82DFA3
P2860
Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Targeting PI3K/Akt/mTOR signal ...... ostate cancer radioresistance.
@en
type
label
Targeting PI3K/Akt/mTOR signal ...... ostate cancer radioresistance.
@en
prefLabel
Targeting PI3K/Akt/mTOR signal ...... ostate cancer radioresistance.
@en
P2093
P1476
Targeting PI3K/Akt/mTOR signal ...... ostate cancer radioresistance.
@en
P2093
Jingli Hao
Joseph Bucci
Paul J Cozzi
Peter H Graham
P304
P356
10.1016/J.CRITREVONC.2015.07.005
P50
P577
2015-07-18T00:00:00Z